Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-07

Clinical Trial Update: A Clinical Trial to Evaluate the HeartWare MVAD® System (MVAdvantage) [NA]

View source ↗

Summary

A clinical trial evaluating the HeartWare MVAD System for heart failure was terminated, with results posted on 2020-04-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HeartWare MVAD System (MVAdvantage)

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure | NA | Status: TERMINATED | Results posted: 2020-04-07